BDO Releases 2022/2023 CRO Insights Report
Employee turnover continues to impact the global market for talent in Clinical Research Organizations. The companies that will be successful in not only retaining top talent but also in recruiting will employ innovative approaches to their reward strategies.
This Insights Report is based on results from the recently published BDO CRO Industry Global Compensation & Turnover Survey. This Insights Report discusses how now, more than ever, companies are digging deep to find ways to make sure employees stay, which is stirring the buzz term “The Great Retention.” A few key topics covered in this Insights Report include:
- The talent shortage exacerbates high turnover and results in shortened tenure
- The influence of salary increases on turnover
- Career opportunities help combat the turnover challenge
- Attraction and retention in times of economic uncertainty
BDO’s annual CRO Industry Global Compensation & Turnover Survey collects data for 268 positions in the US and 55 countries outside of the US. This survey is designed to help clinical research outsourcing companies develop confidence in their pay levels by providing data necessary to gain insight into their compensation practices relative to the market.
Download the report here.
Reference
2022/2023 Clinical Research Organization Compensation & Turnover Insights Report. (2023, January 24). BDO.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
